On the anniversary of Medicare, Lower Drug Prices Now is joining Members of Congress, seniors, veterans, labor leaders, tribal leaders, faith leaders, patients and local organizers to hold 18 events across the country calling on the Senate to allow Medicare to negotiate drug prices in the budget reconciliation bill currently being negotiated.
The Florida Alliance for Retired Americans celebrated the 56th birthday of Medicare and Medicaid on Friday; the group is calling on Congress to lower prescription drug prices.
Delaying the Medicare rebate rule is a step in the right direction for patients struggling to afford their prescription medication. But preventing cost-shifting is not a substitute for real reforms that rein in drug corporations’ monopoly power to raise prices anytime they want.
Wild has sent a letter to Democratic leadership urging them to include Medicare negotiation power in the upcoming reconciliation bill.
This settlement makes a mockery of justice. While four of the most profitable drug corporations in the world agree to share a fraction of their profits with victims of opioids, not one of the executives responsible for this epidemic is being held accountable.
A Green Bay resident writes in support of HR3, a Democratic bill that would enact several measures to lower drug costs.
A chance for meaningful drug pricing reform is upon us, dozens of purchasers, healthcare and employer groups contend. But Congress needs to capitalize on its “time-limited” opportunity, or the problem could stagnate or worsen.
